FDA warning of opioid interaction with serotonergics

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1595卷 / 1期

关键词：

D O I：

10.1007/s40278-016-16034-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[41] A Boxed Warning for Montelukast: The FDA Perspective
Clarridge, Katherine
Chin, Stacy
Eworuke, Efe
Seymour, Sally
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2638 - 2641
[42] No FDA warning label for doxazosin as yet
Reactions Weekly, 2001, 856 (1) : 2 - 2
[43] FDA Calls for Boxed Warning for Metoclopramide
Lang, Les
GASTROENTEROLOGY, 2009, 136 (07) : 2039 - 2039
[44] US FDA issues warning on TriCitrasol
Reactions Weekly, 2000, 798 (1) : 2 - 2
[45] FDA Warning: Compounding Anesthetic Creams
不详
NURSE PRACTITIONER, 2007, 32 (02): : 70 - 70
[46] Response to "Opioid warning label"
Busse, Jason W.
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (42) : E1319 - E1319
[47] Serious allergic reactions with chlorhexidine: FDA warning
Reactions Weekly, 2017, 1639 (1) : 3 - 3
[48] WARNING - FDA MAY SOON SURVEY PRACTICES
GLOYD, JS
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1990, 196 (09) : 1360 - 1360
[49] FDA Anesthesia Warning for Pregnant Women, Children
Stockwell, Serena
AMERICAN JOURNAL OF NURSING, 2017, 117 (04) : 18 - 18
[50] Anesthesia and Developing Brains - Implications of the FDA Warning
Andropoulos, Dean B.
Greene, Michael F.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 905 - 907

← 1 2 3 4 5 →